Danielle Goldfarb, MD

  • 8Articles
  • 43.4KReads
  • 2019–2023Active
  • 4Collaborators
  • 40Citations

About

Danielle Goldfarb, MD, is affiliated with the Banner Sun Health Research Institute in Sun City, Arizona. Since 2019, Dr. Goldfarb has published extensively on Alzheimer disease, focusing on early diagnosis, treatment initiation, and management challenges. Her work also addresses cognitive assessment methods and communication strategies involving patients and care partners. Dr. Goldfarb frequently collaborates with Alireza Atri, Simon Sheard, Anna D. Burke, and Lynn Shaughnessy.

Publications

JCP
Diagnosing and Treating Alzheimer Disease During the Early Stage
Academic Highlights

Diagnosing and Treating Alzheimer Disease During the Early Stage

March 22, 2023

Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what,...
,
JCP
Timely Diagnosis of Alzheimer Disease
Educational Activity

Timely Diagnosis of Alzheimer Disease

August 1, 2022

Early-stage diagnosis of Alzheimer disease leads to prompt treatment initiation and better patient QoL. Learn about new guidelines and technology advances and what’s on the horizon from authorities in...
,
JCP
Treatment of Early-Stage Alzheimer Disease
Educational Activity

Treatment of Early-Stage Alzheimer Disease

August 1, 2022

Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what,...
,
JCP
Educational Activity

Diagnosis & Treatment Advances in Alzheimer Disease

May 11, 2021

Great strides in research on Alzheimer disease diagnostic biomarkers and treatment targets have taken place over the past 2 decades. Listen as Dr Goldfarb highlights exciting developments.
JCP
Patient-Centered Care for Alzheimer Disease
Academic Highlights

Patient-Centered Care for Alzheimer Disease

December 3, 2019

Learn from experts in neurology, psychiatry, neuropsychology, and primary care about working with patients and care partners to create management plans for Alzheimer's disease that ensure safety, optimize patient...
, , , et al
JCP
Educational Activity

Addressing Challenges in Alzheimer's Disease

September 24, 2019

In a series of brief video segments, experts in neurology, psychiatry, and primary care discuss the diagnosis and treatment of Alzheimer's disease.
, ,
JCP
Educational Activity

Cognitive Assessment for Alzheimer's Disease

June 25, 2019

Meaningful benefits can be derived from the evaluation of cognition in older adults when there is possible cognitive impairment and dementia. Here, experts explain how brief cognitive assessment tools...
, , , et al
JCP
Educational Activity

Disclosure of Dementia Diagnosis

March 19, 2019

Disclosing a diagnosis of dementia can be one of the most challenging aspects of care for clinicians. However difficult the diagnosis is to give, disclosing the diagnosis in a...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe